Literature Archives

For interventional pulmonologists, Bronchosolve demonstrated robust discrimination for lung nodule malignancy risk compared to the VA model with an AUC of 0.895 versus 0.870, showing particularly pronounced separation and meaningful risk reclassification in intermediate-sized nodules of 8 to 15 mm.

The study highlights a major capacity and training gap in African interventional pulmonology, driven by regional disparities and equipment shortages, with 49.0% of respondents reporting no structured IP training.

A structured, multidisciplinary team-driven endosonographic strategy achieved an overall diagnostic yield of 92%, demonstrating high diagnostic and molecular adequacy for both malignant and benign conditions in real-world practice.

While US interventional pulmonology fellowships offer robust exposure to advanced bronchoscopy, training programs must address disparities in procedural exposure to ensure every graduating fellow achieves true independent mastery in high-risk interventions.

Nonocclusive balloon dilation is a safe and physiologically favorable technique that preserves gas exchange during critical airway dilations, with mean minimum oxygen saturation during the procedure at 96.1% increasing significantly to a final saturation of 98.6% at the conclusion of the intervention (P = 0.009).

Incorporating transbronchial cryoprobe biopsy into robotic bronchoscopy workflows enhances tissue acquisition quality and facilitates comprehensive molecular testing by providing larger tissue fragments with preserved architecture and avoiding extensive crush artifact.

For interventional pulmonologists, this decade-long review reinforces that intrabronchial valves are a viable, lung-sparing alternative for refractory persistent air leaks, with success heavily relying on meticulous pre-procedural mapping and management of complications like device migration.

For centers without cone-beam CT, confirming tool-in-virtual-lesion alignment across four or more fluoroscopic planes dramatically increases diagnostic success, yielding a nearly 14-fold higher likelihood of diagnostic success (OR = 13.6, P = 0.01) especially in lesions lacking an R-EBUS signal.

For interventional pulmonologists, baseline symptom assessment using the modified Medical Research Council dyspnea score is a vital prognostic tool, as asymptomatic patients with an mMRC score of 0 had a 100% estimated 5-year progression-free survival rate compared to symptomatic patients (log-rank P = 0.0023).

Without advanced imaging like cone-beam CT, there is no significant difference in diagnostic yield or safety between the Ion and Monarch platforms (parsimonious OR 1.5, 95% CI 0.9-2.7, P = 0.15), meaning proceduralists should rely on nodule size and the bronchus sign as the primary drivers of success.

Whole-lung lavage remains a cornerstone IP procedure for PAP, but bronchoscopists must stay informed on competing medical therapies.

Liquid nitrogen cryospray represents a promising bronchoscopic intervention for targeted mucosal ablation and regeneration in severe chronic bronchitis.